Literature DB >> 3503572

Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.

J Bigby1, J Dunn, L Goldman, J B Adams, P Jen, C S Landefeld, A L Komaroff.   

Abstract

The quality of primary medical care was assessed by studying the events leading to 686 emergency admissions of patients from our hospital-based primary care practice. Independent physician reviewers determined that 59 (9 percent) of the admissions were potentially preventable; 40 were due to iatrogenic factors including inadequate follow-up and adverse drug reactions, 12 were due to lack of patient compliance, and seven were due to both iatrogenesis and noncompliance. Adverse drug reactions were the most common cause of iatrogenesis, and warfarin was the drug that most commonly caused an adverse reaction. Inadequate follow-up of abnormal physical findings, symptoms, and laboratory test results was also important. Patients with preventable admissions had more medical diagnoses (4.9 versus 4.1, p less than 0.01), were prescribed more medications (4.5 versus 3.7, p less than 0.01), and were older (66.5 years versus 60.2 years, p less than 0.01) than patients whose admissions were not preventable. It is concluded that a small percentage of emergency hospitalizations may be preventable and that systematic review of emergency hospitalizations may provide a means of measuring the quality of primary medical care.

Entities:  

Mesh:

Year:  1987        PMID: 3503572     DOI: 10.1016/0002-9343(87)90938-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

1.  Lack of awareness of community-acquired adverse drug reactions upon hospital admission : dimensions and consequences of a dilemma.

Authors:  Harald Dormann; Manfred Criegee-Rieck; Antje Neubert; Tobias Egger; Arnim Geise; Sabine Krebs; Thomas Schneider; Micha Levy; Eckhart Hahn; Kay Brune
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Preventability of drug-related harms - part I: a systematic review.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 3.  Which drugs cause preventable admissions to hospital? A systematic review.

Authors:  R L Howard; A J Avery; S Slavenburg; S Royal; G Pipe; P Lucassen; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06-26       Impact factor: 4.335

4.  Predicting readmissions of elderly patients.

Authors:  D M Smith
Journal:  J Gen Intern Med       Date:  1991 Sep-Oct       Impact factor: 5.128

5.  The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis.

Authors:  Anne J Leendertse; Djurre Visser; Antoine C G Egberts; Patricia M L A van den Bemt
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

6.  Enhancing Administrative Data to Predict Emergency Department Utilization: The Role of Neighborhood Sociodemographics.

Authors:  Lisa M Lines; Allison B Rosen; Arlene S Ash
Journal:  J Health Care Poor Underserved       Date:  2017

Review 7.  Pharmaceutical care versus traditional drug treatment. Is there a difference?

Authors:  C D Hepler; T J Grainger-Rousseau
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

8.  Presenting clinical pharmacology and therapeutics: general introduction.

Authors:  T P De Vries
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

9.  Preventable Admissions on a General Medicine Service: Prevalence, Causes and Comparison with AHRQ Prevention Quality Indicators-A Cross-Sectional Analysis.

Authors:  Krishna K Patel; Nirav Vakharia; James Pile; Erik H Howell; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2016-02-18       Impact factor: 5.128

Review 10.  Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Authors:  Bengt I Eriksson; Ola E Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.